11/20/2024

University of Washington

Researchers at Tempus partnered with the University of Washington to study the genomic alteration (GA) landscape of pure urothelial (UC) and histologic subtypes of bladder cancer.

This analysis promises to yield insight into variant histology bladder cancers to better understand their lack of clinical response, and potentially identify modes of therapeutic intervention.

This study was presented at the ASCO GU Cancers Symposium in 2024.

Related Content

View more
  • post image
    03/25/2025

    AI & ML in action: Unlocking RWD with GenAI through Tempus Lens

    Discover how Tempus is equipping researchers with innovative AI solutions to fully leverage the potential of multimodal data. Gain insights from a panel of leaders across healthcare and life sciences as they discuss the impact of these advanced tools on delivering insights with speed.

    Secure your recording now.

    Watch replay
  • post image
    03/11/2025

    Case Report: Pharmacogenomic testing and mood stabilizers

    This real-world case demonstrates how the Tempus nP pharmacogenomic test facilitated a personalized treatment approach for a patient with bipolar disorder.

    Read more
  • post image
    03/05/2025

    Evolving outcomes research: The convergence of data, technology, and collaboration

    This white paper offers an in-depth examination of the evolving field of outcomes research, focusing on the integration of real-world data and advanced analytics to improve patient outcomes. In it, we discuss the current state of the industry, the challenges of data standardization and quality, and the collaborative efforts shaping the future. Download to explore innovative approaches that are transforming outcomes research and driving the development of patient-centric healthcare solutions.

    Read more